Influence of Inflammatory Cytokines on Arteriogenesis

REFERENCES

• Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. (1998). Monocyte activation in angiogen-esis and collateral growth in the rabbit hindlimb. J Clin Invest 101:40–50.
   PubMedGoogle Scholar
• Bae MK, Ahn MY, Jeong JW, Bae MH, Lee YM, Bae SK, Park JW, Kim KR, Kim KW. (2002). Jabl inter-acts directly with HIF- 1 alpha and regulates its sta-bility. J Biol Chem 277:9–12.
   PubMed Web of Science ®Google Scholar
• Bauters C, Six I, Meurice T, Van Belle E. (1999). Growth factors and endothelial dysfunction. Drugs 59:11–15.
   Google Scholar
• Bouloumie A, Drexler HC, Lafontan M, Busse R. (1998). Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83:1059–1066.
   PubMed Web of Science ®Google Scholar
• Bouloumie A, Marumo T, Lafontan M, Busse R. (1999). Leptin induces oxidative stress in human en-dothelial cells. FASEB J 13:1231–1238.
   PubMed Web of Science ®Google Scholar
• Buschmann IR, Hoefer IE, van Royen N, Katzer E, Braun-Dulleaus R, Heil M, Kostin S, Bode C, Schaper W. (2001). GM-CSF: a strong arteriogenic factor act-ing by amplification of monocyte function. Athero-sclerosis 159:343–356.
   PubMed Web of Science ®Google Scholar
• Cai W, Vosschulte R, Afsah-Hedjri A, Koltai S, Kocsis E, Scholz D, Kostin S, Schaper W, Schaper J. (2000). Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis. J Mol Cell Cardio/ 32:997–1011.
   Google Scholar
• Cai WJ, Koltai S, Kocsis E, Scholz D, Schaper W, Schaper J. (2001). Connexin37, not Cx40 and Cx43, is induced in vascular smooth muscle cells during coronary arteriogenesis. J Mol Cell Cardio/ 33:957–967.
   Google Scholar
• Carmeliet P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389–395.
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Cotten D. Molecular analysis of blood vessel formation and disease. (1997). Am J Physiol 273:H2091–H2104.
   Google Scholar
• Chae JK, Kim I, Lim ST, Chung MJ, Kim WH, Kim HG, Ko JK, Koh GY. (2000). Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20:2573–2578.
   PubMed Web of Science ®Google Scholar
• Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W. (1996). The vascular en-dothelial growth factor receptor Flt-1 mediates bio-logical activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271:17629–17634.
   Google Scholar
• De Marchis F, Ribatti D, Giampietri C, Lentini A, Faraone D, Scoccianti M, Capogrossi MC, Facchiano A. (2002). Platelet-derived growth factor inhibits ba-sic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor. Blood 99:2045–2053.
   PubMed Web of Science ®Google Scholar
• Demetri GD, Antman KH. (1992). Granulocyte-macrophage colony-stimulating factor (GM-CSF): preclinical and clinical investigations. Semin Oncol 19:362–385.
   PubMed Web of Science ®Google Scholar
• Denecker G, Vandenabeele P. Grooten J, Penning LC, Declercq W, Beyaert R, Buurman WA, Fiers W. (1997). Differential role of calcium in tumor necrosis factor-mediated apoptosis and secretion of granulo-cyte-macrophage colony-stimulating factor in a T cell hybridoma. Cytokine 9:631–638.
   Google Scholar
• Dimmeler S, Dernbach E, Zeiher AM. (2000). Phos-phorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 477:258–262.
   PubMed Web of Science ®Google Scholar
• Donahue RE, Wang EA, Stone DK, Kamen R, Wong GG, Sehgal PK, Nathan DG, Clark SC. (1986). Stimulation of hematopoiesis in primates by continu-ous infusion of recombinant human GM-CSF. Nature 321:872–875.
   PubMed Web of Science ®Google Scholar
• Doukas J, Blease K, Craig D, Ma C, Chandler LA, Sosnowski BA, Pierce GF. (2002). Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle. Mol Ther 5:517–527.
   PubMed Web of Science ®Google Scholar
• Eischen A, Vincent F, Bergerat JP, Louis B, Faradji A, Bohbot A, Oberling F. (1991). Long term cultures of human monocytes in vitro. Impact of GM-CSF on sur-vival and differentiation. J Immunol Methods 143: 209–221.
   PubMed Web of Science ®Google Scholar
• George D. (2001). Platelet-derived growth factor re-ceptors: a therapeutic target in solid tumors. Semin Oncol 28:27–33.
   Google Scholar
• Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, Rosenzweig A. (1999). MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398:718–723.
   PubMed Web of Science ®Google Scholar
• Hart MN, Fabry Z, Love-Homan L, Keiner J, Sade-wasser KL, Moore SA. (1992). Brain microvascular smooth muscle and endothelial cells produce granu-locyte macrophage colony-stimulating factor and sup-port colony formation of granulocyte-macrophage-like cells. Am J Pathol 141:421–427.
   PubMed Web of Science ®Google Scholar
• Hawighorst T, Skobe M, Streit M, Hong YK, Velasco P, Brown LF, Riccardi L, Lange-Asschenfeldt B, Det-mar M. (2002). Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth. Am J Pathol 160:1381–1392.
   Google Scholar
• Heil M, Clauss M, Suzuki K, Buschmann IR, Willu- weit A, Fischer S, Schaper W. (2000). Vascular en-dothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via in-creased integrin expression. Eur J Cell Biol 79:850–857.
   PubMed Web of Science ®Google Scholar
• Heil M, Ziegelhoeffer T, Helisch A, Wagner S, Martin S, Kuziel W, Schaper W. (2002). Arteriogenesis (col-lateral artery growth) after femoral artery occlusion is reduced in mice lacking CC-chemokine-receptor-2. Circulation 106:1390.
   Google Scholar
• Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M, Schaper W. (2002). Blood monocyte con-centration is critical for enhancement of collateral ar-tery growth. Am J Physiol Heart Circ Physiol 283:H2411–H2419.
   Google Scholar
• Hoefer IE, van Royen N, Buschmann IR, Piek JJ, Schaper W. (2001). Time course of arteriogenesis fol-lowing femoral artery occlusion in the rabbit. Cardio-vasc Res 49:609–617.
   Google Scholar
• Hoefer IE, van Royen N, Rectenwald JE, Bray EJ, Abouhamze Z, Moldawer LL, Voskuil M, Piek JJ, Buschmann IR, Ozaki CK. (2002). Direct evidence for tumor necrosis factor-alpha signaling in arterio-genesis. Circulation 105:1639–1641.
   PubMed Web of Science ®Google Scholar
• Hoekman K. (2001). 5U6668, a multitargeted angio-genesis inhibitor. Cancer J 7:S134–S138.
   Google Scholar
• Ishibashi T, Nakazato K, Shindo J, Yokoyama K, Maruyama Y. (1996). Effects of granulocyte-macrophage colony-stimulating factor on the levels of VLDL and LDL receptor mRNAs in vivo. J Athero-scler Thromb 2:76–80.
   Google Scholar
• Ishida A, Murray J, Saito Y, Kanthou C, Benzakour O, Shibuya M, Wijelath ES. (2001). Expression of vas-cular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol 188:359–368.
   PubMed Web of Science ®Google Scholar
• Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. (1997). Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80:829–837.
   PubMed Web of Science ®Google Scholar
• Jimenez B, Volpert OV. (2001). Mechanistic insights on the inhibition of tumor angiogenesis. J Mol Med 78:663–672.
   PubMedGoogle Scholar
• Jones TC. (1993). The effects of rhGM-CSF on mac-rophage function. Eur J Cancer 29A: S10–S13.
   Google Scholar
• Kanaki T, Bujo H, Mori S, Yanjuan Z, Takahashi K, Yokote K, Morisaki N, Saito Y. (2002). Functional analysis of aortic endothelial cells expressing mutant PDGF receptors with respect to expression of matrix metalloproteinase-3. Biochem Biophys Res Commun 294:231–237.
   Google Scholar
• Klein B, Le Bousse-Kerdiles C, Smadja-Joffe F, Prag-nell I, Ostertag W, Jasmin C. (1982). A study of added GM-CSF independent granulocyte and macro-phage precursors in mouse spleen infected with my-eloproliferative sarcoma virus (MPSV). Exp Hematol 10:373–382.
   Google Scholar
• Koh GY, Kim I, Kwak HJ, Yun MJ, Leem JC. (2002). Biomedical significance of endothelial cell specific growth factor, angiopoietin. Exp Mol Med 34:1–11.
   PubMed Web of Science ®Google Scholar
• Lazarous DF, Unger EF, Epstein SE, Stine A, Arevalo JL, Chew EY, Quyyumi AA. (2000). Basic fibroblast growth factor in patients with intermittent claudica-tion: results of a phase I trial. J Am Coll Cardiol 36: 1239–1244.
   PubMed Web of Science ®Google Scholar
• Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ, An-nex BH. (2002). Therapeutic angiogenesis with re-combinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomized trial. Lancet 359:2053–2058.
   Google Scholar
• Libby P, Sukhova G, Lee RT, Galis ZS. (1995). Cy-tokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 25:S9–S12.
   PubMed Web of Science ®Google Scholar
• Mantzoros CS, Moschos SJ. (1998). Leptin: in search of role(s) in human physiology and pathophysiology. Clin Endocrinol (Oxj9 49:551–567.
   Google Scholar
• Michiels C, Minet E, Michel G, Mottet D, Piret JP, Raes M. (2001). HIF-1 and AP-1 cooperate to in-crease gene expression in hypoxia: role of MAP ki-nases. IUBMB Life 52:49–53.
   Google Scholar
• Nagel T, Resnick N, Atkinson WJ, Dewey CF Jr, Gim-brone MA Jr. (1994). Shear stress selectively upregu-lates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin In-vest 94:885–891.
   PubMed Web of Science ®Google Scholar
• Negishi M, Lu D, Zhang YQ, Sawada Y, Sasaki T, Kayo T, Ando J, Izumi T, Kurabayashi M, Kojima I, Masuda H, Takeuchi T. (2001). Upregulatory expres-sion of furin and transforming growth factor-beta by fluid shear stress in vascular endothelial cells. Arte-rioscler Thromb Vasc Biol 21:785–790.
   Google Scholar
• Neufeld G, Cohen T, Shraga N, Lange T, Kessler O, Herzog Y. (2002). The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 12:13–19.
   PubMed Web of Science ®Google Scholar
• O'Connor DS, Schechner JS, Adida C, Mesri M, Ro-thermel AL, Li F, Nath AK, Pober JS, Altieri DC. (2000). Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 156:393–398.
   PubMed Web of Science ®Google Scholar
• Oda A, Taniguchi T, Yokoyama M. (2001). Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 47:141–150.
   PubMedGoogle Scholar
• Papetti M, Herman IM. (2002). Mechanisms of nor-mal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282:C947–C970.
   Google Scholar
• Parhami F, Tintut Y, Ballard A, Fogelman AM, De-mer LL. (2001). Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 88:954–960.
   Google Scholar
• Pegram MD, Reese DM. (2002). Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular en- dothelial growth factor. Semin Oncol 29:29–37.
   PubMed Web of Science ®Google Scholar
• Pintucci G, Moscatelli D, Saponara F, Biernacki PR, Baumann FG, Bizekis C, Galloway AC, Basilico C, Mignatti P. (2002). Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J 16:598–600.
   PubMed Web of Science ®Google Scholar
• Plenz G, Koenig C, Severs NJ, Robenek H. (1997). Smooth muscle cells express granulocyte-macrophage colony-stimulating factor in the undiseased and ath-erosclerotic human coronary artery. Arterioscler Thromb Vasc Biol 17:2489–2499.
   Google Scholar
• Presta M, Rusnati M, Dell'Era P. Tanghetti E, Urbi-nati C, Giuliani R, Leali D. (2000). Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells. Adv Exp Med Biol 476:7–34.
   Google Scholar
• Risau W. (1997). Mechanisms of angiogenesis. Na-ture 386:671–674.
   PubMed Web of Science ®Google Scholar
• Rosen LS. (2002). Clinical experience with angiogen-esis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control 9: 36–44.
   PubMedGoogle Scholar
• Schaper W, Buschmann I. (1999). Arteriogenesis, the good and bad of it. Cardiovasc Res 43:835–837.
   PubMed Web of Science ®Google Scholar
• Schaper W, Buschmann I. (1999). Collateral circula-tion and diabetes. Circulation 99:2224–2226.
   Google Scholar
• Schaper W, Ito WD. (1996). Molecular mechanisms of coronary collateral vessel growth. Circ Res 79:911–919.
   PubMed Web of Science ®Google Scholar
• Schoppmann SF, Birner P. Stockl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D. (2002). Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161: 947–956.
   PubMed Web of Science ®Google Scholar
• Scotland RS, Morales-Ruiz M, Chen Y, Yu J, Rudic RD, Fulton D, Gratton JP, Sessa WC. (2002). Func-tional reconstitution of endothelial nitric oxide syn-thase reveals the importance of serine 1179 in endo-thelium-dependent vasomotion. Circ Res 90:904–910.
   PubMed Web of Science ®Google Scholar
• Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S, Eberli FR, Meier B. (2001). Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 104:2012–2017.
   PubMed Web of Science ®Google Scholar
• Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Har-vey VS, Dvorak HF. (1983). Tumor cells secrete a vascular permeability factor that promotes accumu-lation of ascites fluid. Science 219:983–985.
   PubMed Web of Science ®Google Scholar
• Shyy YJ, Hsieh HJ, Usami S, Chien S. (1994). Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc Nall Acad Sci USA 91: 4678–4682.
   PubMed Web of Science ®Google Scholar
• Sierra-Honigmann MR, Nath AK, Murakami C, Gar-cia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR. (1998). Biological action of leptin as an angiogenic factor. Science 281:1683–1686.
   PubMed Web of Science ®Google Scholar
• Spinetti G, Camarda G, Bernardini G, Romano Di Peppe S, Capogrossi MC, Napotitan° M. (2001). The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells. Biochem Biophys Res Commun 289:19–24.
   Google Scholar
• Valkovic T, Dobrila F, Melato M, Sasso F, Rizzardi C, Jonjic N. (2002). Correlation between vascular endo-thelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast car-cinoma. Virchows Arch 440:583–588.
   PubMed Web of Science ®Google Scholar
• van Royen N, Hoefer I, Buschmann I, Heil M, Kostin S, Deindl E, Vogel S, Korff T, Augustin H, Bode C, Piek JJ, Schaper W. (2002). Exogenous application of transforming growth factor beta 1 stimulates arterio-genesis in the peripheral circulation. FASEB J 16: 432–434.
   PubMed Web of Science ®Google Scholar
• Vikse BE, Bostad L, Aasarod K, Lysebo DE, Iversen BM. (2002). Prognostic factors in mesangioprolifera-tive glomerulonephritis. Nephrol Dial Transplant 17: 1603–1613.
   PubMed Web of Science ®Google Scholar
• Visconti RP, Richardson CD, Sato TN. (2002). Or-chestration of angiogenesis and arteriovenous contri-bution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Nall Acad Sci USA 99: 8219–8224.
   PubMed Web of Science ®Google Scholar
• Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M. (1987). En-dothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracel-lular matrix. Proc Nall Acad Sci USA 84:2292–2296.
   Google Scholar
• Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB. (1987). Transforming growth factor type beta induces mono-cyte chemotaxis and growth factor production. Proc Nall Acad Sci USA 84:5788–5792.
   PubMed Web of Science ®Google Scholar
• Wetzel MA, Steele AD, Henderson EE, Rogers TJ. (2002). The effect of X4 and R5 HIV-1 on C, C-C, and C-X-C chemokines during the early stages of in-fection in human PBMCs. Virology 292:6–15.
   PubMed Web of Science ®Google Scholar
• Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ. (1988). Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Bio-phys Res Commun 157:793–800.
   PubMed Web of Science ®Google Scholar
• Yanagisawa-Miwa A, Uchida Y, Nakamura F, To-maru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, Ito H. (1992). Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257:1401–1403.
   PubMed Web of Science ®Google Scholar
• Zhang H, Issekutz AC. (2002). Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent 5U6668. Am J Pathol 160:2219–2230.
   PubMed Web of Science ®Google Scholar
• Zimmermann R, Arras M, Ullmann C, Strasser R, Sack S, Mollnau H, Schaper J, Schaper W. (1997). Time course of mitosis and collateral growth follow-ing coronary microembolization in the porcine heart. Cell Tissue Res 287:583–590.
   Google Scholar
• Zubilewicz A, Hecquet C, Jeanny JC, Soubrane G, Courtois Y, Mascarelli F. (2001). Two distinct signal-ing pathways are involved in FGF2-stimulated pro-liferation of choriocapillary endothelial cells: a com-parative study with VEGF Oncogene 20:1403–1413.
   PubMed Web of Science ®Google Scholar